Abstract
The literature about superparamagnetic iron oxide-enhanced MR imaging, computed tomography (CT) and PET (positron emission tomography using fluorine-18 labelled fluoro-deoxy-glucose) in detection of liver metastases (LM) from colorectal cancer is reviewed in this update. Special emphasis is given to studies with surgical standard of reference allowing for the lesion-by-lesion sensitivity to be determined. Based on the review, it is concluded that state-of-the-art anatomical imaging, e.g., SPIO-enhanced MR imaging and multidetector CT (MDCT), must be considered more sensitive than PET in detection of individual LM, due to technical developments in MR imaging, such as liver specific contrast agents, modern sequences and high performance gradients, and in modern MDCT have increased the performance of these modalities. MR imaging with a liver specific contrast agent is recommended for the preoperative evaluation before liver surgery for LM because of high sensitivity and better discrimination between small LM and cysts compared to MDCT. PET or PET/CT can be used for detection of extra-hepatic tumor before liver surgery.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130
Baker ME, Pelley R. (1995) Hepatic metastases: basic principles and implications for radiologists. Radiology 197:329–337
Weiss L, Grundmann E, Torhorst J, et al. (1986) Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150:195–203
Wood CB, Gillis CR, Blumgart LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285–288
Cunningham D, Pyrhonen S, James RD, et al. (1998) Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352:1413–1418
Scheele J, Stang R, Altendorf-Hofmann A, et al. (1995) Resection of colorectal liver metastases. World J Surg 19:59–71
Ohlsson B, Stenram U, Tranberg K-G (1998) Resection of colorectal liver metastases: 25-year experience. World J Surg 22:268–277
van Erkel AR, Pijl ME, van den Berg-Huysmans, et al. (2002) Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates. Radiology 224:404–409
Dietrich CF, Kratzer W, Strobel D, et al. (2006) Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 12:1699–1705
Cervone A, Sardi A, Conaway GL (2000) Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 66:611–615
Foroutani A, Garland AM, Berger E, et al. (2000) Laparoscopic ultrasound vs. triphasic computed tomography for detecting liver tumors. Arch Surg 135:933–937
Moran B, O´Rourke N, Plant G, et al. (1995) Computed tomographic portography in preoperative imaging of hepatic neoplasms. Br J Surg 82:669–671
Hagspiel KD, Neidl KF, Eichenberger AC, et al. (1995) Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanec MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 196:471–478
Ward J, Guthrie JA, Wilson D, et al. (2003) Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging—comparison of optimized sequences. Radiology 228:709–718
Ward J, Robinson PJ, Guthrie JA, et al. (2005) Liver metastases in candidates for hepatic resection:comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 237:170–180
Lencioni R, Donati F, Cioni D, et al. (1998) Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography. MAGMA 7:76–83
Del Frate C, Bazzocchi M, Mortele KJ, et al. (2002) Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced MR imaging examinations. Radiology 225:766–772
Ward J, Chen F, Guthrie JA, et al. (2000) Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternate-free response receiver operating characteristic analyses. Radiology 214:159–166
Furuhata T, Okita K, Tsuruma T, et al. (2003) Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas. Dig Surg 20:321–325
Blakeborough A, Ward J, Wilson D, et al. (1997) Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 203:759–765
Ward J, Naik KS, Guthrie JA, et al. (1999) Hepatic lesion detection:comparison of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analyses. Radiology 210:459–466
Van Beers BE, Lacrosse M, Jamart J, et al. (1997) Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging. Am J Roentgenol 168:713–717
Kim YK, Lee JM, Kim CS, et al. (2005) Detection of liver metastases: gadobenate dimeglumine-enhanced three dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced-MR imaging. Eur Radiol 15:220–228
Kim YK, Ko SW, Hwang SB, et al. (2005) Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol (E-pub ahead of publication) 10.1007/s00330–005-0140-y
Ba-Ssalamah A, Heinz-Peer G, Schima W, et al. (2000) Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 11:665–672
Kim HJ, Kim KW, Byun JH, et al. (2006) Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. Am J Roentgenol 186:1059–1066
Soyer P, Poccard M, Boudiaf P, et al. (2004) Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathological findings. Radiology 231:413–420
Haider MA, Amitai MM, Rappaport DC, et al. (2002) Multi-detector row helical CT in preoperative assessment of small (≤1.5 cm) liver metastases: is thinner collimation better? Radiology 225:137–142
Weg N, Scheer MR, Gabor MP, et al. (1998) Liver lesions: improved detection with dual-detector-array CT and routine 2.5 mm thin collimation. Radiology 209:417–426
Kawata S, Murakami T, Kim T, et al. (2002) Multidetector CT: diagnostic impact of slice thickness on detection of hypervascular hepatocellular carcinoma. Am J Roentgenol 79:61–66
Numminen K, Isoniemi H, Halavaara J, et al. (2005) Preoperative assesment of focal liver lesions: multidetector computed tomography challenges magnetic resonance imaging. Acta Radiologica 46:9–15
Valls C, Andiá E, Sánchez A, et al. (2001) Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 218:55–60
Regge D, Campanella D, Anselmetti GC, et al. (2006) Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol 61:338–347
Kinkel K, Lu Y, Both M, et al. (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224:748–756
Bipat S, van Leeuwen MS, Comans EFI, et al. (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 237:123–131
Huebner RH, Park KC, Shepherd JE, et al. (2000) A meta-analysis of the literature for whole-body FDG PET in detection of recurrent colorectal cancer. J Nucl Med 41:1177–1189
Rohren EM, Paulson EK, Hagge R, et al. (2002) The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 27:550–555
Delbeke D, Vitola JV, Sandler MP, et al. (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201
Lai DTM, Fulham M, Stephen MS, et al. (1996) The role of whole-body positron emission tomography with [18F] fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131:703–707
Vitola JV, Delbelke D, Sandler MP, et al. (1996) Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171:21–26
Imdahl A, Reinhardt MJ, Nitzsche EU, et al. (2000) Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences. Arch Surg 385:129–134
Böhm B, Voth M, Geoghegan J, et al. (2004) Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 130:266–272
Ruers TJM, Langenhoff BS, Neeleman N, et al. (2002) Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20:388–395
Rydzewski B, Dehdashti F, Gordon BA, et al. (2002) Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. Am J Roentgenol 178:353–358
Truant S, Huglo D, Hebbar M, et al. (2005) Prospective evaluation of the impact of [18F] fluoro-2-deoxyglucose positron emission tomography of respectable colorectal liver metastases. Br J Surg 92:362–369
Fong Y, Saldinger PF, Akhurst T, et al. (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282–287
Akhurst T, Kates TJ, Mazumdar M, et al. (2005) Recent chemotherapy reduces the sensitivity of [18F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 23:8713–8726
Selzner M, Hany TF, Wildbrett P, et al. (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027–1036
Sahani DV, Kalva SP, Fischmann AJ, et al. (2005) Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium enhanced liver MRI and whole-body FDG PET. Am J Roentgenol 185:239–246
Bartolozzi C, Donati F, Cioni D, et al. (2004) Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 14:14–20
Dietrich CF, Ignee A, Trojan J, et al. (2004) Improved characterization of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 53:401–405
Votrubova J, Blohlavek O, Jaruskova M, et al. (2006) The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 33:779–784
Lonneux M, Reffad AM, Detry R, et al. (2002) FDG-PET improves the staging and selection of patients with recurrent colorectal cancer. Eur J Nucl Med 29:915–921
Schüssler-Fiorenza CM, Mahvi DM, Niederhuber J, et al. (2004) Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases. J Gastrointest Surg 8:150–158
Fong Y, Fortner J, Sun RL, et al. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases. Ann Surg 3:309–321
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rappeport, E.D., Loft, A. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography. Abdom Imaging 32, 624–634 (2007). https://doi.org/10.1007/s00261-007-9297-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-007-9297-y